CLINICAL
NEWS
“Some advantages of gastric bypass over
sleeve gastrectomy have emerged during followup,” Dr. Schauer said. “At 5 years, gastric bypass
maintained greater weight loss than sleeve
gastrecomy while requiring fewer medications.”
He also noted that the final STAMPEDE results
might help expand the population of patients in
whom bariatric surgery may be considered for
improving glycemic control, especially those patients with significant
medical problems caused by or made
worse by their weight.
“Most clinical guidelines and insurance policies for bariatric surgery limit
access to patients with a BMI of 35 or
above,” Dr. Schauer added. “Our 5-year
results demonstrate that glycemic
improvement in patients with a BMI
of 27 to 34 is durable at least up to 5
years.” Importantly, he said, patients
with a starting BMI < 35 achieved just
as much benefit from surgery as patients with a BMI > 35 at study entry.
Editor’s Note: For additional information, read our previous CSWN cover
story on Bypassing Obesity: http://
bit.ly/2f9otk7
REFERENCES:
1. Schauer PR, Kashyap SR, Wolski K,et al.
Bariatric surgery versus intensive medical
therapy in obese patients with diabetes. N
Engl J Med 2012;366:1567-76.
2. Schauer PR, Bhatt DL, Kirwan JP, et al.
STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for
diabetes--3-year outcomes. N Engl J Med
2014;370:2002-13.
American College of Cardiology Extended Learning
Lessons from a Legend:
Jane Somerville and Pediatric Cardiology
C
ongenital heart disease is the most common
type of birth defect. Due to advances in
treating infants and children with congenital cardiac abnormalities, there is a new challenge:
PEOPLE ARE COUNTING ON
THIS MIDDLE-AGED FATHER OF 3...
EFFIENT® (PRASUGREL)
CAN HELP
PROTECT
HIM AFTER
STEMI-PCI
Take-aways
• In the final, 5-year follow-up of
the influential STAMPEDE trial,
bariatric surgery’s beneficial
effects on blood glucose control
in mild and moderately obese
patients with type 2 diabetes
persisted for up to 5 years, with
the advantage over a medicationonly approach widening over time.
• The effects of both surgical
procedures studied normalized
glucose levels, although this specific
effect did diminish over time with
some late complications noted with
surgery.
• The final STAMPEDE results might
help expand the population of
patients in whom bariatric surgery
may be considered for improving
glycemic control, especially those
with significant medical problems
caused by or made worse by their
weight.
22
CardioSource WorldNews
Learn more at EffientHCP.com
taking care of the growing number of cases of adult
congenital heart disease (ACHD), also known as
GUCH for grown-up congenital heart disease.
Indeed, for the first time, there is a larger popula-